サマリー

ヒト用狂犬病ワクチン（ベロ細胞）の世界市場規模は、2022年の100万米ドルから2029年には100万米ドルになると予測されており、2023年から2029年までの年平均成長率は %と予測されています。
ヒト用狂犬病ワクチン（ベロ細胞）の米国市場は、2023年から2029年までのCAGR %で、2022年の100万米ドルから2029年には100万米ドルまで増加すると予測されています。
ヒト用狂犬病ワクチン（ベロ細胞）の中国市場は、2023年から2029年までのCAGR %で、2022年の百万米ドルから2029年には百万米ドルに増加すると推定されます。
ヒト用狂犬病ワクチン（ベロ細胞）のヨーロッパ市場は、2023年から2029年までのCAGR %で、2022年の百万米ドルから2029年には百万米ドルに増加すると推定されます。
世界の主要なヒト狂犬病ワクチン（ヴェロ細胞）プレーヤーは、Liaoning Chengda、Guangzhou Nuocheng、Ningbo Rong'an, Hualan Bio-vaccine, Sanofi Pasteur SA, Bharat Biotech, Bavarian Nordic, Serum Institute of India Pvt. and Chengdu Kanghua Biologyなどです。収益面では、2022年には世界の2大企業がほぼ％のシェアを占めています。
狂犬病は、狂犬病ウイルスによって引き起こされる急性感染症である。臨床的に有効な治療法はありません。狂犬病は、臨床的に有効な治療法がなく、曝露後にワクチン接種を行うことで、狂犬病ウイルスに対する免疫の産生を促し、狂犬病の予防につなげることができます。
LPI（エルピーアイ）の最新リサーチレポート「ヒト用狂犬病ワクチン（ベロ細胞）産業予測」は、過去の販売実績から2022年の世界のヒト用狂犬病ワクチン（ベロ細胞）総販売実績を検証し、2023年から2029年のヒト用狂犬病ワクチン（ベロ細胞）販売予測について地域や市場分野ごとに包括的に分析しています。ヒト狂犬病ワクチン（ベロ細胞）の売上を地域別、市場分野別、サブセクター別に分類し、世界のヒト狂犬病ワクチン（ベロ細胞）産業の百万米ドル単位の詳細分析を提供します。
本インサイトレポートでは、世界のヒト用狂犬病ワクチン（ベロ細胞）業界を包括的に分析し、製品区分、会社設立、収益、市場シェア、最新開発、M&A活動に関する主要動向を明らかにします。また、本レポートでは、加速する世界のヒト狂犬病ワクチン（ベロ細胞）市場におけるこれらの企業の独自のポジションをよりよく理解するために、ヒト狂犬病ワクチン（ベロ細胞）のポートフォリオと能力、市場参入戦略、市場ポジション、地理的フットプリントに焦点を当てて、主要グローバル企業の戦略を分析しています。
本インサイトレポートでは、ヒト用狂犬病ワクチン（ベロ細胞）の世界的な見通しを形成する主要な市場動向、推進要因、影響要因を評価し、タイプ別、アプリケーション別、地域別、市場規模別に予測を行い、新たな機会のポケットを明らかにします。何百ものボトムアップの定性的・定量的な市場インプットに基づく透明性の高い手法により、この調査予測は、世界のヒト用狂犬病ワクチン（ベロ細胞）の現状と将来の軌道について非常にニュアンスのある見方を提供します。
本レポートでは、製品タイプ、用途、主要メーカー、主要地域・国別のヒト用狂犬病ワクチン（ベロ細胞）市場の包括的な概要、市場シェア、および成長機会を紹介します。
市場のセグメンテーション
タイプ別セグメンテーション
0.5ml
1ミリリットル
用途別セグメンテーション
病院
診療所
また、本レポートでは、地域別に市場を分割しています：
米州
アメリカ
カナダ
メキシコ
ブラジル
APAC
中国
日本
韓国
東南アジア
インド
オーストラリア
欧州
ドイツ
フランス
イギリス
イタリア
ロシア
中近東・アフリカ
エジプト
南アフリカ
イスラエル
トルコ
GCC諸国
以下の企業は、主要な専門家から収集した情報に基づいて選択されており、企業のカバレッジ、製品ポートフォリオ、市場浸透度を分析したものである。
遼寧省成大
広州諾成(Nuocheng)
寧波栄安(Ningbo Rong'an)
花蘭咲バイオバクシン
サノフィ・パストゥールSA
バーラト・バイオテック
バイエルン・ノルディック
セラムインスティテュートオブインディアPvt.
成都康華生物学
長春珠玉の生物学
大連雅麗峰
吉林慧康生物製薬有限公司（Jilin Huikang Biopharmaceutical Co.
本レポートで扱う主な質問
世界のヒト用狂犬病ワクチン（ベロ細胞）市場の10年後の展望は？
世界および地域別に、ヒト用狂犬病ワクチン（Vero Cell）市場の成長を促進する要因は何か？
市場別、地域別で最も早く成長するのはどの技術か？
ヒト用狂犬病ワクチン（Vero Cell）の市場機会は、エンドマーケットの規模によってどのように変化するのか？
ヒト用狂犬病ワクチン（Vero Cell）のタイプ別、用途別内訳は？
COVID-19とロシア・ウクライナ戦争の影響力は？

ページTOPに戻る

目次

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Human Rabies Vaccine (Vero Cell) Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Human Rabies Vaccine (Vero Cell) by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Human Rabies Vaccine (Vero Cell) by Country/Region, 2018, 2022 & 2029
2.2 Human Rabies Vaccine (Vero Cell) Segment by Type
2.2.1 0.5ml
2.2.2 1ml
2.3 Human Rabies Vaccine (Vero Cell) Sales by Type
2.3.1 Global Human Rabies Vaccine (Vero Cell) Sales Market Share by Type (2018-2023)
2.3.2 Global Human Rabies Vaccine (Vero Cell) Revenue and Market Share by Type (2018-2023)
2.3.3 Global Human Rabies Vaccine (Vero Cell) Sale Price by Type (2018-2023)
2.4 Human Rabies Vaccine (Vero Cell) Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 Human Rabies Vaccine (Vero Cell) Sales by Application
2.5.1 Global Human Rabies Vaccine (Vero Cell) Sale Market Share by Application (2018-2023)
2.5.2 Global Human Rabies Vaccine (Vero Cell) Revenue and Market Share by Application (2018-2023)
2.5.3 Global Human Rabies Vaccine (Vero Cell) Sale Price by Application (2018-2023)
3 Global Human Rabies Vaccine (Vero Cell) by Company
3.1 Global Human Rabies Vaccine (Vero Cell) Breakdown Data by Company
3.1.1 Global Human Rabies Vaccine (Vero Cell) Annual Sales by Company (2018-2023)
3.1.2 Global Human Rabies Vaccine (Vero Cell) Sales Market Share by Company (2018-2023)
3.2 Global Human Rabies Vaccine (Vero Cell) Annual Revenue by Company (2018-2023)
3.2.1 Global Human Rabies Vaccine (Vero Cell) Revenue by Company (2018-2023)
3.2.2 Global Human Rabies Vaccine (Vero Cell) Revenue Market Share by Company (2018-2023)
3.3 Global Human Rabies Vaccine (Vero Cell) Sale Price by Company
3.4 Key Manufacturers Human Rabies Vaccine (Vero Cell) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Human Rabies Vaccine (Vero Cell) Product Location Distribution
3.4.2 Players Human Rabies Vaccine (Vero Cell) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Human Rabies Vaccine (Vero Cell) by Geographic Region
4.1 World Historic Human Rabies Vaccine (Vero Cell) Market Size by Geographic Region (2018-2023)
4.1.1 Global Human Rabies Vaccine (Vero Cell) Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Human Rabies Vaccine (Vero Cell) Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Human Rabies Vaccine (Vero Cell) Market Size by Country/Region (2018-2023)
4.2.1 Global Human Rabies Vaccine (Vero Cell) Annual Sales by Country/Region (2018-2023)
4.2.2 Global Human Rabies Vaccine (Vero Cell) Annual Revenue by Country/Region (2018-2023)
4.3 Americas Human Rabies Vaccine (Vero Cell) Sales Growth
4.4 APAC Human Rabies Vaccine (Vero Cell) Sales Growth
4.5 Europe Human Rabies Vaccine (Vero Cell) Sales Growth
4.6 Middle East & Africa Human Rabies Vaccine (Vero Cell) Sales Growth
5 Americas
5.1 Americas Human Rabies Vaccine (Vero Cell) Sales by Country
5.1.1 Americas Human Rabies Vaccine (Vero Cell) Sales by Country (2018-2023)
5.1.2 Americas Human Rabies Vaccine (Vero Cell) Revenue by Country (2018-2023)
5.2 Americas Human Rabies Vaccine (Vero Cell) Sales by Type
5.3 Americas Human Rabies Vaccine (Vero Cell) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Rabies Vaccine (Vero Cell) Sales by Region
6.1.1 APAC Human Rabies Vaccine (Vero Cell) Sales by Region (2018-2023)
6.1.2 APAC Human Rabies Vaccine (Vero Cell) Revenue by Region (2018-2023)
6.2 APAC Human Rabies Vaccine (Vero Cell) Sales by Type
6.3 APAC Human Rabies Vaccine (Vero Cell) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Human Rabies Vaccine (Vero Cell) by Country
7.1.1 Europe Human Rabies Vaccine (Vero Cell) Sales by Country (2018-2023)
7.1.2 Europe Human Rabies Vaccine (Vero Cell) Revenue by Country (2018-2023)
7.2 Europe Human Rabies Vaccine (Vero Cell) Sales by Type
7.3 Europe Human Rabies Vaccine (Vero Cell) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Human Rabies Vaccine (Vero Cell) by Country
8.1.1 Middle East & Africa Human Rabies Vaccine (Vero Cell) Sales by Country (2018-2023)
8.1.2 Middle East & Africa Human Rabies Vaccine (Vero Cell) Revenue by Country (2018-2023)
8.2 Middle East & Africa Human Rabies Vaccine (Vero Cell) Sales by Type
8.3 Middle East & Africa Human Rabies Vaccine (Vero Cell) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Human Rabies Vaccine (Vero Cell)
10.3 Manufacturing Process Analysis of Human Rabies Vaccine (Vero Cell)
10.4 Industry Chain Structure of Human Rabies Vaccine (Vero Cell)
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Human Rabies Vaccine (Vero Cell) Distributors
11.3 Human Rabies Vaccine (Vero Cell) Customer
12 World Forecast Review for Human Rabies Vaccine (Vero Cell) by Geographic Region
12.1 Global Human Rabies Vaccine (Vero Cell) Market Size Forecast by Region
12.1.1 Global Human Rabies Vaccine (Vero Cell) Forecast by Region (2024-2029)
12.1.2 Global Human Rabies Vaccine (Vero Cell) Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Human Rabies Vaccine (Vero Cell) Forecast by Type
12.7 Global Human Rabies Vaccine (Vero Cell) Forecast by Application
13 Key Players Analysis
13.1 Liaoning Chengda
13.1.1 Liaoning Chengda Company Information
13.1.2 Liaoning Chengda Human Rabies Vaccine (Vero Cell) Product Portfolios and Specifications
13.1.3 Liaoning Chengda Human Rabies Vaccine (Vero Cell) Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Liaoning Chengda Main Business Overview
13.1.5 Liaoning Chengda Latest Developments
13.2 Guangzhou Nuocheng
13.2.1 Guangzhou Nuocheng Company Information
13.2.2 Guangzhou Nuocheng Human Rabies Vaccine (Vero Cell) Product Portfolios and Specifications
13.2.3 Guangzhou Nuocheng Human Rabies Vaccine (Vero Cell) Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Guangzhou Nuocheng Main Business Overview
13.2.5 Guangzhou Nuocheng Latest Developments
13.3 Ningbo Rong'an
13.3.1 Ningbo Rong'an Company Information
13.3.2 Ningbo Rong'an Human Rabies Vaccine (Vero Cell) Product Portfolios and Specifications
13.3.3 Ningbo Rong'an Human Rabies Vaccine (Vero Cell) Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Ningbo Rong'an Main Business Overview
13.3.5 Ningbo Rong'an Latest Developments
13.4 Hualan Bio-vaccine
13.4.1 Hualan Bio-vaccine Company Information
13.4.2 Hualan Bio-vaccine Human Rabies Vaccine (Vero Cell) Product Portfolios and Specifications
13.4.3 Hualan Bio-vaccine Human Rabies Vaccine (Vero Cell) Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Hualan Bio-vaccine Main Business Overview
13.4.5 Hualan Bio-vaccine Latest Developments
13.5 Sanofi Pasteur SA
13.5.1 Sanofi Pasteur SA Company Information
13.5.2 Sanofi Pasteur SA Human Rabies Vaccine (Vero Cell) Product Portfolios and Specifications
13.5.3 Sanofi Pasteur SA Human Rabies Vaccine (Vero Cell) Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Sanofi Pasteur SA Main Business Overview
13.5.5 Sanofi Pasteur SA Latest Developments
13.6 Bharat Biotech
13.6.1 Bharat Biotech Company Information
13.6.2 Bharat Biotech Human Rabies Vaccine (Vero Cell) Product Portfolios and Specifications
13.6.3 Bharat Biotech Human Rabies Vaccine (Vero Cell) Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Bharat Biotech Main Business Overview
13.6.5 Bharat Biotech Latest Developments
13.7 Bavarian Nordic
13.7.1 Bavarian Nordic Company Information
13.7.2 Bavarian Nordic Human Rabies Vaccine (Vero Cell) Product Portfolios and Specifications
13.7.3 Bavarian Nordic Human Rabies Vaccine (Vero Cell) Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Bavarian Nordic Main Business Overview
13.7.5 Bavarian Nordic Latest Developments
13.8 Serum Institute of India Pvt.
13.8.1 Serum Institute of India Pvt. Company Information
13.8.2 Serum Institute of India Pvt. Human Rabies Vaccine (Vero Cell) Product Portfolios and Specifications
13.8.3 Serum Institute of India Pvt. Human Rabies Vaccine (Vero Cell) Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Serum Institute of India Pvt. Main Business Overview
13.8.5 Serum Institute of India Pvt. Latest Developments
13.9 Chengdu Kanghua Biology
13.9.1 Chengdu Kanghua Biology Company Information
13.9.2 Chengdu Kanghua Biology Human Rabies Vaccine (Vero Cell) Product Portfolios and Specifications
13.9.3 Chengdu Kanghua Biology Human Rabies Vaccine (Vero Cell) Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Chengdu Kanghua Biology Main Business Overview
13.9.5 Chengdu Kanghua Biology Latest Developments
13.10 Changchun Zhuoyi Biology
13.10.1 Changchun Zhuoyi Biology Company Information
13.10.2 Changchun Zhuoyi Biology Human Rabies Vaccine (Vero Cell) Product Portfolios and Specifications
13.10.3 Changchun Zhuoyi Biology Human Rabies Vaccine (Vero Cell) Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Changchun Zhuoyi Biology Main Business Overview
13.10.5 Changchun Zhuoyi Biology Latest Developments
13.11 Dalian Yali Peak
13.11.1 Dalian Yali Peak Company Information
13.11.2 Dalian Yali Peak Human Rabies Vaccine (Vero Cell) Product Portfolios and Specifications
13.11.3 Dalian Yali Peak Human Rabies Vaccine (Vero Cell) Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Dalian Yali Peak Main Business Overview
13.11.5 Dalian Yali Peak Latest Developments
13.12 Jilin Huikang Biopharmaceutical Co., Ltd.
13.12.1 Jilin Huikang Biopharmaceutical Co., Ltd. Company Information
13.12.2 Jilin Huikang Biopharmaceutical Co., Ltd. Human Rabies Vaccine (Vero Cell) Product Portfolios and Specifications
13.12.3 Jilin Huikang Biopharmaceutical Co., Ltd. Human Rabies Vaccine (Vero Cell) Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Jilin Huikang Biopharmaceutical Co., Ltd. Main Business Overview
13.12.5 Jilin Huikang Biopharmaceutical Co., Ltd. Latest Developments
14 Research Findings and Conclusion

ページTOPに戻る

図表リスト

List of Tables
Table 1. Human Rabies Vaccine (Vero Cell) Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Human Rabies Vaccine (Vero Cell) Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 0.5ml
Table 4. Major Players of 1ml
Table 5. Global Human Rabies Vaccine (Vero Cell) Sales by Type (2018-2023) & (K Units)
Table 6. Global Human Rabies Vaccine (Vero Cell) Sales Market Share by Type (2018-2023)
Table 7. Global Human Rabies Vaccine (Vero Cell) Revenue by Type (2018-2023) & ($ million)
Table 8. Global Human Rabies Vaccine (Vero Cell) Revenue Market Share by Type (2018-2023)
Table 9. Global Human Rabies Vaccine (Vero Cell) Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Human Rabies Vaccine (Vero Cell) Sales by Application (2018-2023) & (K Units)
Table 11. Global Human Rabies Vaccine (Vero Cell) Sales Market Share by Application (2018-2023)
Table 12. Global Human Rabies Vaccine (Vero Cell) Revenue by Application (2018-2023)
Table 13. Global Human Rabies Vaccine (Vero Cell) Revenue Market Share by Application (2018-2023)
Table 14. Global Human Rabies Vaccine (Vero Cell) Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Human Rabies Vaccine (Vero Cell) Sales by Company (2018-2023) & (K Units)
Table 16. Global Human Rabies Vaccine (Vero Cell) Sales Market Share by Company (2018-2023)
Table 17. Global Human Rabies Vaccine (Vero Cell) Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Human Rabies Vaccine (Vero Cell) Revenue Market Share by Company (2018-2023)
Table 19. Global Human Rabies Vaccine (Vero Cell) Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Human Rabies Vaccine (Vero Cell) Producing Area Distribution and Sales Area
Table 21. Players Human Rabies Vaccine (Vero Cell) Products Offered
Table 22. Human Rabies Vaccine (Vero Cell) Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Human Rabies Vaccine (Vero Cell) Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Human Rabies Vaccine (Vero Cell) Sales Market Share Geographic Region (2018-2023)
Table 27. Global Human Rabies Vaccine (Vero Cell) Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Human Rabies Vaccine (Vero Cell) Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Human Rabies Vaccine (Vero Cell) Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Human Rabies Vaccine (Vero Cell) Sales Market Share by Country/Region (2018-2023)
Table 31. Global Human Rabies Vaccine (Vero Cell) Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Human Rabies Vaccine (Vero Cell) Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Human Rabies Vaccine (Vero Cell) Sales by Country (2018-2023) & (K Units)
Table 34. Americas Human Rabies Vaccine (Vero Cell) Sales Market Share by Country (2018-2023)
Table 35. Americas Human Rabies Vaccine (Vero Cell) Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Human Rabies Vaccine (Vero Cell) Revenue Market Share by Country (2018-2023)
Table 37. Americas Human Rabies Vaccine (Vero Cell) Sales by Type (2018-2023) & (K Units)
Table 38. Americas Human Rabies Vaccine (Vero Cell) Sales by Application (2018-2023) & (K Units)
Table 39. APAC Human Rabies Vaccine (Vero Cell) Sales by Region (2018-2023) & (K Units)
Table 40. APAC Human Rabies Vaccine (Vero Cell) Sales Market Share by Region (2018-2023)
Table 41. APAC Human Rabies Vaccine (Vero Cell) Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Human Rabies Vaccine (Vero Cell) Revenue Market Share by Region (2018-2023)
Table 43. APAC Human Rabies Vaccine (Vero Cell) Sales by Type (2018-2023) & (K Units)
Table 44. APAC Human Rabies Vaccine (Vero Cell) Sales by Application (2018-2023) & (K Units)
Table 45. Europe Human Rabies Vaccine (Vero Cell) Sales by Country (2018-2023) & (K Units)
Table 46. Europe Human Rabies Vaccine (Vero Cell) Sales Market Share by Country (2018-2023)
Table 47. Europe Human Rabies Vaccine (Vero Cell) Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Human Rabies Vaccine (Vero Cell) Revenue Market Share by Country (2018-2023)
Table 49. Europe Human Rabies Vaccine (Vero Cell) Sales by Type (2018-2023) & (K Units)
Table 50. Europe Human Rabies Vaccine (Vero Cell) Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Human Rabies Vaccine (Vero Cell) Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Human Rabies Vaccine (Vero Cell) Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Human Rabies Vaccine (Vero Cell) Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Human Rabies Vaccine (Vero Cell) Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Human Rabies Vaccine (Vero Cell) Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Human Rabies Vaccine (Vero Cell) Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Human Rabies Vaccine (Vero Cell)
Table 58. Key Market Challenges & Risks of Human Rabies Vaccine (Vero Cell)
Table 59. Key Industry Trends of Human Rabies Vaccine (Vero Cell)
Table 60. Human Rabies Vaccine (Vero Cell) Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Human Rabies Vaccine (Vero Cell) Distributors List
Table 63. Human Rabies Vaccine (Vero Cell) Customer List
Table 64. Global Human Rabies Vaccine (Vero Cell) Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Human Rabies Vaccine (Vero Cell) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Human Rabies Vaccine (Vero Cell) Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Human Rabies Vaccine (Vero Cell) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Human Rabies Vaccine (Vero Cell) Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Human Rabies Vaccine (Vero Cell) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Human Rabies Vaccine (Vero Cell) Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Human Rabies Vaccine (Vero Cell) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Human Rabies Vaccine (Vero Cell) Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Human Rabies Vaccine (Vero Cell) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Human Rabies Vaccine (Vero Cell) Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Human Rabies Vaccine (Vero Cell) Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Human Rabies Vaccine (Vero Cell) Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Human Rabies Vaccine (Vero Cell) Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Liaoning Chengda Basic Information, Human Rabies Vaccine (Vero Cell) Manufacturing Base, Sales Area and Its Competitors
Table 79. Liaoning Chengda Human Rabies Vaccine (Vero Cell) Product Portfolios and Specifications
Table 80. Liaoning Chengda Human Rabies Vaccine (Vero Cell) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Liaoning Chengda Main Business
Table 82. Liaoning Chengda Latest Developments
Table 83. Guangzhou Nuocheng Basic Information, Human Rabies Vaccine (Vero Cell) Manufacturing Base, Sales Area and Its Competitors
Table 84. Guangzhou Nuocheng Human Rabies Vaccine (Vero Cell) Product Portfolios and Specifications
Table 85. Guangzhou Nuocheng Human Rabies Vaccine (Vero Cell) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Guangzhou Nuocheng Main Business
Table 87. Guangzhou Nuocheng Latest Developments
Table 88. Ningbo Rong'an Basic Information, Human Rabies Vaccine (Vero Cell) Manufacturing Base, Sales Area and Its Competitors
Table 89. Ningbo Rong'an Human Rabies Vaccine (Vero Cell) Product Portfolios and Specifications
Table 90. Ningbo Rong'an Human Rabies Vaccine (Vero Cell) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Ningbo Rong'an Main Business
Table 92. Ningbo Rong'an Latest Developments
Table 93. Hualan Bio-vaccine Basic Information, Human Rabies Vaccine (Vero Cell) Manufacturing Base, Sales Area and Its Competitors
Table 94. Hualan Bio-vaccine Human Rabies Vaccine (Vero Cell) Product Portfolios and Specifications
Table 95. Hualan Bio-vaccine Human Rabies Vaccine (Vero Cell) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Hualan Bio-vaccine Main Business
Table 97. Hualan Bio-vaccine Latest Developments
Table 98. Sanofi Pasteur SA Basic Information, Human Rabies Vaccine (Vero Cell) Manufacturing Base, Sales Area and Its Competitors
Table 99. Sanofi Pasteur SA Human Rabies Vaccine (Vero Cell) Product Portfolios and Specifications
Table 100. Sanofi Pasteur SA Human Rabies Vaccine (Vero Cell) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Sanofi Pasteur SA Main Business
Table 102. Sanofi Pasteur SA Latest Developments
Table 103. Bharat Biotech Basic Information, Human Rabies Vaccine (Vero Cell) Manufacturing Base, Sales Area and Its Competitors
Table 104. Bharat Biotech Human Rabies Vaccine (Vero Cell) Product Portfolios and Specifications
Table 105. Bharat Biotech Human Rabies Vaccine (Vero Cell) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Bharat Biotech Main Business
Table 107. Bharat Biotech Latest Developments
Table 108. Bavarian Nordic Basic Information, Human Rabies Vaccine (Vero Cell) Manufacturing Base, Sales Area and Its Competitors
Table 109. Bavarian Nordic Human Rabies Vaccine (Vero Cell) Product Portfolios and Specifications
Table 110. Bavarian Nordic Human Rabies Vaccine (Vero Cell) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Bavarian Nordic Main Business
Table 112. Bavarian Nordic Latest Developments
Table 113. Serum Institute of India Pvt. Basic Information, Human Rabies Vaccine (Vero Cell) Manufacturing Base, Sales Area and Its Competitors
Table 114. Serum Institute of India Pvt. Human Rabies Vaccine (Vero Cell) Product Portfolios and Specifications
Table 115. Serum Institute of India Pvt. Human Rabies Vaccine (Vero Cell) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Serum Institute of India Pvt. Main Business
Table 117. Serum Institute of India Pvt. Latest Developments
Table 118. Chengdu Kanghua Biology Basic Information, Human Rabies Vaccine (Vero Cell) Manufacturing Base, Sales Area and Its Competitors
Table 119. Chengdu Kanghua Biology Human Rabies Vaccine (Vero Cell) Product Portfolios and Specifications
Table 120. Chengdu Kanghua Biology Human Rabies Vaccine (Vero Cell) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Chengdu Kanghua Biology Main Business
Table 122. Chengdu Kanghua Biology Latest Developments
Table 123. Changchun Zhuoyi Biology Basic Information, Human Rabies Vaccine (Vero Cell) Manufacturing Base, Sales Area and Its Competitors
Table 124. Changchun Zhuoyi Biology Human Rabies Vaccine (Vero Cell) Product Portfolios and Specifications
Table 125. Changchun Zhuoyi Biology Human Rabies Vaccine (Vero Cell) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Changchun Zhuoyi Biology Main Business
Table 127. Changchun Zhuoyi Biology Latest Developments
Table 128. Dalian Yali Peak Basic Information, Human Rabies Vaccine (Vero Cell) Manufacturing Base, Sales Area and Its Competitors
Table 129. Dalian Yali Peak Human Rabies Vaccine (Vero Cell) Product Portfolios and Specifications
Table 130. Dalian Yali Peak Human Rabies Vaccine (Vero Cell) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Dalian Yali Peak Main Business
Table 132. Dalian Yali Peak Latest Developments
Table 133. Jilin Huikang Biopharmaceutical Co., Ltd. Basic Information, Human Rabies Vaccine (Vero Cell) Manufacturing Base, Sales Area and Its Competitors
Table 134. Jilin Huikang Biopharmaceutical Co., Ltd. Human Rabies Vaccine (Vero Cell) Product Portfolios and Specifications
Table 135. Jilin Huikang Biopharmaceutical Co., Ltd. Human Rabies Vaccine (Vero Cell) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Jilin Huikang Biopharmaceutical Co., Ltd. Main Business
Table 137. Jilin Huikang Biopharmaceutical Co., Ltd. Latest Developments
List of Figures
Figure 1. Picture of Human Rabies Vaccine (Vero Cell)
Figure 2. Human Rabies Vaccine (Vero Cell) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Human Rabies Vaccine (Vero Cell) Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Human Rabies Vaccine (Vero Cell) Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Human Rabies Vaccine (Vero Cell) Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 0.5ml
Figure 10. Product Picture of 1ml
Figure 11. Global Human Rabies Vaccine (Vero Cell) Sales Market Share by Type in 2022
Figure 12. Global Human Rabies Vaccine (Vero Cell) Revenue Market Share by Type (2018-2023)
Figure 13. Human Rabies Vaccine (Vero Cell) Consumed in Hospital
Figure 14. Global Human Rabies Vaccine (Vero Cell) Market: Hospital (2018-2023) & (K Units)
Figure 15. Human Rabies Vaccine (Vero Cell) Consumed in Clinic
Figure 16. Global Human Rabies Vaccine (Vero Cell) Market: Clinic (2018-2023) & (K Units)
Figure 17. Global Human Rabies Vaccine (Vero Cell) Sales Market Share by Application (2022)
Figure 18. Global Human Rabies Vaccine (Vero Cell) Revenue Market Share by Application in 2022
Figure 19. Human Rabies Vaccine (Vero Cell) Sales Market by Company in 2022 (K Units)
Figure 20. Global Human Rabies Vaccine (Vero Cell) Sales Market Share by Company in 2022
Figure 21. Human Rabies Vaccine (Vero Cell) Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Human Rabies Vaccine (Vero Cell) Revenue Market Share by Company in 2022
Figure 23. Global Human Rabies Vaccine (Vero Cell) Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Human Rabies Vaccine (Vero Cell) Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Human Rabies Vaccine (Vero Cell) Sales 2018-2023 (K Units)
Figure 26. Americas Human Rabies Vaccine (Vero Cell) Revenue 2018-2023 ($ Millions)
Figure 27. APAC Human Rabies Vaccine (Vero Cell) Sales 2018-2023 (K Units)
Figure 28. APAC Human Rabies Vaccine (Vero Cell) Revenue 2018-2023 ($ Millions)
Figure 29. Europe Human Rabies Vaccine (Vero Cell) Sales 2018-2023 (K Units)
Figure 30. Europe Human Rabies Vaccine (Vero Cell) Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Human Rabies Vaccine (Vero Cell) Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Human Rabies Vaccine (Vero Cell) Revenue 2018-2023 ($ Millions)
Figure 33. Americas Human Rabies Vaccine (Vero Cell) Sales Market Share by Country in 2022
Figure 34. Americas Human Rabies Vaccine (Vero Cell) Revenue Market Share by Country in 2022
Figure 35. Americas Human Rabies Vaccine (Vero Cell) Sales Market Share by Type (2018-2023)
Figure 36. Americas Human Rabies Vaccine (Vero Cell) Sales Market Share by Application (2018-2023)
Figure 37. United States Human Rabies Vaccine (Vero Cell) Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Human Rabies Vaccine (Vero Cell) Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Human Rabies Vaccine (Vero Cell) Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Human Rabies Vaccine (Vero Cell) Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Human Rabies Vaccine (Vero Cell) Sales Market Share by Region in 2022
Figure 42. APAC Human Rabies Vaccine (Vero Cell) Revenue Market Share by Regions in 2022
Figure 43. APAC Human Rabies Vaccine (Vero Cell) Sales Market Share by Type (2018-2023)
Figure 44. APAC Human Rabies Vaccine (Vero Cell) Sales Market Share by Application (2018-2023)
Figure 45. China Human Rabies Vaccine (Vero Cell) Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Human Rabies Vaccine (Vero Cell) Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Human Rabies Vaccine (Vero Cell) Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Human Rabies Vaccine (Vero Cell) Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Human Rabies Vaccine (Vero Cell) Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Human Rabies Vaccine (Vero Cell) Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Human Rabies Vaccine (Vero Cell) Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Human Rabies Vaccine (Vero Cell) Sales Market Share by Country in 2022
Figure 53. Europe Human Rabies Vaccine (Vero Cell) Revenue Market Share by Country in 2022
Figure 54. Europe Human Rabies Vaccine (Vero Cell) Sales Market Share by Type (2018-2023)
Figure 55. Europe Human Rabies Vaccine (Vero Cell) Sales Market Share by Application (2018-2023)
Figure 56. Germany Human Rabies Vaccine (Vero Cell) Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Human Rabies Vaccine (Vero Cell) Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Human Rabies Vaccine (Vero Cell) Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Human Rabies Vaccine (Vero Cell) Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Human Rabies Vaccine (Vero Cell) Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Human Rabies Vaccine (Vero Cell) Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Human Rabies Vaccine (Vero Cell) Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Human Rabies Vaccine (Vero Cell) Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Human Rabies Vaccine (Vero Cell) Sales Market Share by Application (2018-2023)
Figure 65. Egypt Human Rabies Vaccine (Vero Cell) Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Human Rabies Vaccine (Vero Cell) Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Human Rabies Vaccine (Vero Cell) Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Human Rabies Vaccine (Vero Cell) Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Human Rabies Vaccine (Vero Cell) Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Human Rabies Vaccine (Vero Cell) in 2022
Figure 71. Manufacturing Process Analysis of Human Rabies Vaccine (Vero Cell)
Figure 72. Industry Chain Structure of Human Rabies Vaccine (Vero Cell)
Figure 73. Channels of Distribution
Figure 74. Global Human Rabies Vaccine (Vero Cell) Sales Market Forecast by Region (2024-2029)
Figure 75. Global Human Rabies Vaccine (Vero Cell) Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Human Rabies Vaccine (Vero Cell) Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Human Rabies Vaccine (Vero Cell) Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Human Rabies Vaccine (Vero Cell) Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Human Rabies Vaccine (Vero Cell) Revenue Market Share Forecast by Application (2024-2029)